In this context, >90% of SFT express CD34 and STAT6, while a smaller percentage of tumours may be positive for CD99 (70%), EMA (20%), smooth muscle actin (20%) and BCL-2 (30%) [18]. This evidence concerns the gene BCL2 and neoplasm.